A machine learning analysis of 349 lung adenocarcinoma cases identified a 40-lncRNA signature that separated patients by ...

Lung cancer remains the leading cause of cancer-related deaths worldwide, accounting for nearly one in five cancer deaths—around 1.8 million lives lost each year. One of the main reasons is late ...

The Japanese Patent Office has signalled its intention to grant patent protection for bioAffinity Technologies’ noninvasive lung cancer detection technology, expanding the company’s intellectual ...

Lung cancer remains one of the malignancies with the highest incidence and mortality worldwide. Clinical practice has long been plagued by core dilemmas, including insufficient sensitivity in early ...

A computational study combined gene co-expression network analysis and machine learning to nominate twelve candidate ...

Grade 9 learner Brandon Mashandudze received top honours from Harvard Medical School’s Dr Chi-Fu Jeffrey Yang and the ...

Data presented at the 2026 AACR Annual Meeting demonstrated the promise of blood-based lung cancer detection via SimpleScreen Lung. Developers designed SimpleScreen Lung as an artificial intelligence ...

Chief Medical Officer Gordon Downie, MD, to host CHEST 2026 Learning Theater on clinical use of CyPath® Lung Presentation to address current challenges in pulmonary nodule management and to discuss ...